View in EDS HTML Full Text PDF Full Text

Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.
Authors: Rovithi M; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Lind JS; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Pham TV; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Voortman J; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Knol JC; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Verheul HM; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Smit EF; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Jimenez CR; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Source: Proteomics. Clinical applications [Proteomics Clin Appl] 2016 Jul; Vol. 10 (7), pp. 743-9. Date of Electronic Publication: 2016 May 27.
Publication Type: Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101298608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1862-8354 (Electronic) Linking ISSN: 18628346 NLM ISO Abbreviation: Proteomics Clin Appl Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27040893
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rovithi+M%22">Rovithi M</searchLink>; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lind+JS%22">Lind JS</searchLink>; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pham+TV%22">Pham TV</searchLink>; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Voortman+J%22">Voortman J</searchLink>; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Knol+JC%22">Knol JC</searchLink>; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Verheul+HM%22">Verheul HM</searchLink>; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Smit+EF%22">Smit EF</searchLink>; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jimenez+CR%22">Jimenez CR</searchLink>; OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101298608%22">Proteomics. Clinical applications</searchLink> [Proteomics Clin Appl] 2016 Jul; Vol. 10 (7), pp. 743-9. <i>Date of Electronic Publication: </i>2016 May 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-VCH%22">Wiley-VCH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101298608 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1862-8354 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218628346%22">18628346 </searchLink><i>NLM ISO Abbreviation: </i>Proteomics Clin Appl <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27040893
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/prca.201600025
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 743
    Titles:
      – TitleFull: Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rovithi M
      – PersonEntity:
          Name:
            NameFull: Lind JS
      – PersonEntity:
          Name:
            NameFull: Pham TV
      – PersonEntity:
          Name:
            NameFull: Voortman J
      – PersonEntity:
          Name:
            NameFull: Knol JC
      – PersonEntity:
          Name:
            NameFull: Verheul HM
      – PersonEntity:
          Name:
            NameFull: Smit EF
      – PersonEntity:
          Name:
            NameFull: Jimenez CR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2016 Jul
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1862-8354
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Proteomics. Clinical applications
              Type: main
ResultId 1